“In Vitro Evidence Supports Cell Cycle Arrest by Alkyl-Phospholipid Erufosine in Pancreatic Cancer Cell Line”. 2026. Biomedical Current Insights 2 (2): 69-74. https://doi.org/10.63626/c4gxd642.